Fairchem Organics Q1 FY27 Revenue at ₹176.15 Cr, Profit ₹10.01 Cr
Fairchem Organics reported unaudited results for Q1 FY27. Revenue from operations increased to ₹176.15 crore from ₹131.06 crore year-on-year. Profit After Tax surged to ₹10.01 crore from ₹1.17 crore. EPS stood at ₹7.95. The Board approved the results on July 27, 2026.
The substantial year-on-year growth in revenue and profit is a material development that is likely to impact investor sentiment and the company's stock price.
The company reported a significant increase in revenue and profit for the quarter compared to the previous year, indicating strong financial performance.
Fairchem Organics Limited has announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors approved these results on July 27, 2026.
Total income for the quarter stood at ₹17,649.32 lakh (₹176.15 crore), a significant increase from ₹13,119.67 lakh (₹131.20 crore) in the same quarter last year. Profit Before Tax (PBT) was ₹1,363.67 lakh (₹13.64 crore), compared to ₹161.56 lakh (₹1.62 crore) in the prior year's quarter. Profit After Tax (PAT) for the quarter was ₹1,001.38 lakh (₹10.01 crore), a substantial rise from ₹117.36 lakh (₹1.17 crore) in the corresponding quarter of the previous year.
The company's revenue from operations for the quarter was ₹17,614.57 lakh (₹176.15 crore), up from ₹13,106.31 lakh (₹131.06 crore) in the same period last year. Expenses, including cost of materials consumed and employee benefits, were ₹16,285.65 lakh (₹162.86 crore) for the quarter. The company reported Earnings Per Share (EPS) of ₹7.95 for the quarter ended June 30, 2026.
The Board Meeting commenced at 11:40 a.m. and concluded at 12:35 p.m. on July 27, 2026. The financial results were reviewed by the Audit Committee and subsequently approved by the Board. The Statutory Auditors, M/s B S R and Co, have issued an unmodified review conclusion on the limited review of the financial results.
What to do with a filing like this
Fairchem Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fairchem Organics Limited. Read the original for the full detail.